Forty Seven Inc (NASDAQ:FTSV) shares were up 7.2% during trading on Tuesday . The company traded as high as $11.49 and last traded at $10.97, approximately 366,900 shares traded hands during mid-day trading. An increase of 69% from the average daily volume of 216,747 shares. The stock had previously closed at $10.23.
A number of analysts have recently commented on FTSV shares. ValuEngine raised Forty Seven from a “hold” rating to a “buy” rating in a research note on Friday, August 16th. Zacks Investment Research downgraded Forty Seven from a “hold” rating to a “sell” rating in a research note on Friday. Oppenheimer dropped their price objective on Forty Seven from $35.00 to $20.00 in a research note on Wednesday, August 14th. HC Wainwright reissued a “buy” rating and issued a $21.00 price objective on shares of Forty Seven in a research note on Wednesday, November 13th. Finally, Mizuho reissued a “buy” rating and issued a $18.00 price objective on shares of Forty Seven in a research note on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. Forty Seven has an average rating of “Buy” and an average price target of $23.14.
The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.48 and a current ratio of 7.48. The stock has a 50 day moving average price of $7.11 and a 200 day moving average price of $9.36. The company has a market cap of $451.93 million, a P/E ratio of -2.93 and a beta of 1.90.
Forty Seven (NASDAQ:FTSV) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.38) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.38). The firm had revenue of $15.68 million during the quarter, compared to the consensus estimate of $15.80 million. As a group, equities research analysts predict that Forty Seven Inc will post -2.63 earnings per share for the current year.
Institutional investors have recently made changes to their positions in the company. River & Mercantile Asset Management LLP acquired a new stake in shares of Forty Seven during the second quarter worth $35,000. Tower Research Capital LLC TRC raised its position in shares of Forty Seven by 5,976.5% during the third quarter. Tower Research Capital LLC TRC now owns 4,132 shares of the company’s stock worth $27,000 after purchasing an additional 4,064 shares during the period. Metropolitan Life Insurance Co NY acquired a new stake in shares of Forty Seven during the first quarter worth $88,000. SG Americas Securities LLC acquired a new stake in shares of Forty Seven during the third quarter worth $73,000. Finally, Swiss National Bank acquired a new stake in shares of Forty Seven during the second quarter worth $184,000. 38.11% of the stock is currently owned by institutional investors.
About Forty Seven (NASDAQ:FTSV)
Forty Seven Inc, a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody.
Further Reading: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Forty Seven Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forty Seven and related companies with MarketBeat.com's FREE daily email newsletter.